It is worth noting, however, the associations we found with high DLL3 expression and the prevalence of genomic alterations associated with NECs versus NETs, particularly considering the propensity of the latter with GEP-NENs versus most prostate and bladder NENs representing carcinomas. The gene discussed is DLL3; the disease is carcinoma.